Adaptimmune in Cancer Collaboration With GlaxoSmithKline

05.06.2014 - Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...